[O27-3] O27-3: Oncology (1)

[O27-3-4] Effect of proton pump inhibitors co-administration on the plasma concentration of erlotinib in patients with non-small cell lung cancer (2nd report)

Masahiro Ogami¹, Takayuki Kaburagi², Toshihiro Shiozawa³, Nobuyuki Hizawa⁴, Atsuhiko Kurosawa⁵, Masato Homma⁶ (1.Ibaraki Prefectural Central Hospital and Sciences, University of Tsukuba, 2.Ibaraki Prefectural Central Hospital and Sciences, University of Tsukuba, 3.University of Tsukuba, 4.University of Tsukuba, 5.Ibaraki Prefectural Central Hospital and Sciences, University of Tsukuba, 6.University of Tsukuba)

Keywords:erlotinib, proton pump inhibitor, H2-blocker, drug interaction,